Literature DB >> 19911810

Label-free cancer cell detection with impedimetric transducers.

Roberto de la Rica1, Sebastian Thompson, Antonio Baldi, Cesar Fernandez-Sanchez, Charles Michael Drain, Hiroshi Matsui.   

Abstract

While cancer is still an implacable disease, many cancers can be cured if they are diagnosed in an early stage. Recently, it was reported that the transformation from normal cells to cancer cells can change their mechanoelastic properties to become softer and more deformable. If some cancer cells are more deformable, then a progressive increase of the volume of softer cancer cells should be induced as an abrupt change in osmolarity is applied. On the basis of this hypothesis, we developed a sensor that can electronically monitor the volume increase of cancer cells under hyposmotic pressure. By this methodology, K:Molv NIH 3T3 cells, 786-O human kidney carcinoma cells, and MPSC-1 ovarian cancer cells were successfully detected within 30 min using on the order of 10 cells. These cancer cells could be detected with the same sensitivity even in the presence of a vast excess of the respective noncancerous cells [NIH 3T3 cells, human embryonic kidney (HEK) 293 cells, ovarian surface epithelial (OSE) cells]. Since the proposed impedimetric sensor could be useful for detecting cancer cells fast and reliably, it could be further implemented in the screening of large populations of tissue samples and the detection of circulating tumor cells for point-of-care applications.

Entities:  

Mesh:

Year:  2009        PMID: 19911810      PMCID: PMC2797081          DOI: 10.1021/ac9021049

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  14 in total

1.  Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence.

Authors:  Jochen Guck; Stefan Schinkinger; Bryan Lincoln; Falk Wottawah; Susanne Ebert; Maren Romeyke; Dominik Lenz; Harold M Erickson; Revathi Ananthakrishnan; Daniel Mitchell; Josef Käs; Sydney Ulvick; Curt Bilby
Journal:  Biophys J       Date:  2005-02-18       Impact factor: 4.033

Review 2.  Proteomic applications for the early detection of cancer.

Authors:  Julia D Wulfkuhle; Lance A Liotta; Emanuel F Petricoin
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

Review 3.  Oncogenic Ras in tumour progression and metastasis.

Authors:  Klaudia Giehl
Journal:  Biol Chem       Date:  2005-03       Impact factor: 3.915

4.  Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device.

Authors:  AmirAli H Talasaz; Ashley A Powell; David E Huber; James G Berbee; Kyung-Ho Roh; Wong Yu; Wenzhong Xiao; Mark M Davis; R Fabian Pease; Michael N Mindrinos; Stefanie S Jeffrey; Ronald W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

Review 5.  The cancer biomarker problem.

Authors:  Charles L Sawyers
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

6.  Atomic force microscopy analysis of cell volume regulation.

Authors:  Chiara Spagnoli; Arthur Beyder; Stephen Besch; Frederick Sachs
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2008-09-22

7.  Isolation of rare circulating tumour cells in cancer patients by microchip technology.

Authors:  Sunitha Nagrath; Lecia V Sequist; Shyamala Maheswaran; Daphne W Bell; Daniel Irimia; Lindsey Ulkus; Matthew R Smith; Eunice L Kwak; Subba Digumarthy; Alona Muzikansky; Paula Ryan; Ulysses J Balis; Ronald G Tompkins; Daniel A Haber; Mehmet Toner
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

8.  Microfluidic electroporative flow cytometry for studying single-cell biomechanics.

Authors:  Ning Bao; Yihong Zhan; Chang Lu
Journal:  Anal Chem       Date:  2008-09-18       Impact factor: 6.986

9.  Nanomechanical analysis of cells from cancer patients.

Authors:  Sarah E Cross; Yu-Sheng Jin; Jianyu Rao; James K Gimzewski
Journal:  Nat Nanotechnol       Date:  2007-12-02       Impact factor: 39.213

10.  An elaborate pathway required for Ras-mediated epigenetic silencing.

Authors:  Claude Gazin; Narendra Wajapeyee; Stephane Gobeil; Ching-Man Virbasius; Michael R Green
Journal:  Nature       Date:  2007-10-25       Impact factor: 49.962

View more
  7 in total

1.  A new strategy for label-free detection of lymphoma cancer cells.

Authors:  Nicola M Martucci; Ilaria Rea; Immacolata Ruggiero; Monica Terracciano; Luca De Stefano; Nunzia Migliaccio; Camillo Palmieri; Giuseppe Scala; Paolo Arcari; Ivo Rendina; Annalisa Lamberti
Journal:  Biomed Opt Express       Date:  2015-03-19       Impact factor: 3.732

2.  Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives.

Authors:  Igor Cima; Chay Wen Yee; Florina S Iliescu; Wai Min Phyo; Kiat Hon Lim; Ciprian Iliescu; Min Han Tan
Journal:  Biomicrofluidics       Date:  2013-01-24       Impact factor: 2.800

Review 3.  Manipulating biological agents and cells in micro-scale volumes for applications in medicine.

Authors:  Savas Tasoglu; Umut Atakan Gurkan; Shuqi Wang; Utkan Demirci
Journal:  Chem Soc Rev       Date:  2013-07-07       Impact factor: 54.564

Review 4.  Layer-by-Layer Assemblies for Cancer Treatment and Diagnosis.

Authors:  Xi Qiu Liu; Catherine Picart
Journal:  Adv Mater       Date:  2015-09-21       Impact factor: 30.849

Review 5.  Cancer Diagnostics and Early Detection Using Electrochemical Aptasensors.

Authors:  Joel Imoukhuede Omage; Ethan Easterday; Jelonia T Rumph; Imamulhaq Brula; Braxton Hill; Jeffrey Kristensen; Dat Thinh Ha; Cristi L Galindo; Michael K Danquah; Naiya Sims; Van Thuan Nguyen
Journal:  Micromachines (Basel)       Date:  2022-03-26       Impact factor: 3.523

6.  Impedimetric detection of mutant p53 biomarker-driven metastatic breast cancers under hyposmotic pressure.

Authors:  Menglu Shi; Nataly Shtraizent; Alla Polotskaia; Jill Bargonetti; Hiroshi Matsui
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

7.  Hot Spot Mutation in TP53 (R248Q) Causes Oncogenic Gain-of-Function Phenotypes in a Breast Cancer Cell Line Derived from an African American patient.

Authors:  Nataly Shtraizent; Hiroshi Matsui; Alla Polotskaia; Jill Bargonetti
Journal:  Int J Environ Res Public Health       Date:  2015-12-22       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.